Klaria Pharma Holding AB (publ.) (KLAR.ST)

SEK 0.29

(-8.63%)

Revenue Summary of Klaria Pharma Holding AB (publ.)

Klaria Pharma Holding AB (publ.)'s latest annual revenue in 2023 was - SEK , down -100.0% from previous year.
Klaria Pharma Holding AB (publ.)'s latest quarterly revenue in 2024 Q2 was - SEK , down -100.0% from previous quarter.
Klaria Pharma Holding AB (publ.) reported a annual revenue of 5.86 Million SEK in annual revenue 2022, down -3.99% from previous year.
Klaria Pharma Holding AB (publ.) reported a annual revenue of 6.11 Million SEK in annual revenue 2021, down -15.35% from previous year.
Klaria Pharma Holding AB (publ.) reported a quarterly revenue of 10 Thousand SEK for 2024 Q1, up 100.14% from previous quarter.
Klaria Pharma Holding AB (publ.) reported a quarterly revenue of - SEK for 2023 Q2, down -100.0% from previous quarter.

Annual Revenue Chart of Klaria Pharma Holding AB (publ.) (2023 - 2014)

Historical Annual Revenue of Klaria Pharma Holding AB (publ.) (2023 - 2014)

Year	Revenue	Revenue Growth
2023	- SEK	-100.0%
2022	5.86 Million SEK	-3.99%
2021	6.11 Million SEK	-15.35%
2020	7.22 Million SEK	70.97%
2019	4.22 Million SEK	550.69%
2018	649 Thousand SEK	-71.47%
2017	2.27 Million SEK	0.0%
2016	- SEK	0.0%
2015	- SEK	0.0%
2014	- SEK	0.0%

Year	Revenue	Revenue Growth
2024 Q2	- SEK	-100.0%
2024 Q1	10 Thousand SEK	100.14%
2023 Q2	- SEK	-100.0%
2023 Q3	619 Thousand SEK	0.0%
2023 FY	- SEK	-100.0%
2023 Q4	-7.14 Million SEK	-1254.6%
2023 Q1	6.52 Million SEK	195.52%
2022 Q2	3.65 Million SEK	0.0%
2022 Q1	- SEK	-100.0%
2022 Q4	2.2 Million SEK	0.0%
2022 FY	5.86 Million SEK	-3.99%
2022 Q3	- SEK	-100.0%
2021 Q3	- SEK	0.0%
2021 Q2	- SEK	0.0%
2021 Q4	6.11 Million SEK	0.0%
2021 FY	6.11 Million SEK	-15.35%
2021 Q1	- SEK	-100.0%
2020 Q3	3.4 Million SEK	207.32%
2020 FY	7.22 Million SEK	70.97%
2020 Q4	1.23 Million SEK	-63.58%
2020 Q2	1.1 Million SEK	-24.8%
2020 Q1	1.47 Million SEK	700.0%
2019 Q3	91 Thousand SEK	-26.61%
2019 Q2	124 Thousand SEK	-96.76%
2019 Q1	3.82 Million SEK	1670.37%
2019 FY	4.22 Million SEK	550.69%
2019 Q4	184 Thousand SEK	102.2%
2018 Q1	83 Thousand SEK	5.06%
2018 FY	649 Thousand SEK	-71.47%
2018 Q3	92 Thousand SEK	-64.34%
2018 Q2	258 Thousand SEK	210.84%
2018 Q4	216 Thousand SEK	134.78%
2017 Q2	- SEK	0.0%
2017 Q4	79 Thousand SEK	-96.53%
2017 Q3	2.27 Million SEK	0.0%
2017 FY	2.27 Million SEK	0.0%
2017 Q1	- SEK	0.0%
2016 Q3	- SEK	0.0%
2016 FY	- SEK	0.0%
2016 Q4	- SEK	0.0%
2016 Q1	- SEK	0.0%
2016 Q2	- SEK	0.0%
2015 Q1	- SEK	0.0%
2015 Q2	- SEK	0.0%
2015 Q3	- SEK	0.0%
2015 Q4	- SEK	0.0%
2015 FY	- SEK	0.0%
2014 FY	- SEK	0.0%

Peer Revenue Comparison of Klaria Pharma Holding AB (publ.)

Name	Revenue	Revenue Difference
AcuCort AB	- SEK	NaN%
AlzeCure Pharma AB (publ)	- SEK	NaN%
BioGaia AB (publ)	1.29 Billion SEK	100.0%
Enzymatica AB (publ)	50.9 Million SEK	100.0%
Enorama Pharma AB (publ)	1.35 Million SEK	100.0%
Gabather AB (publ)	- SEK	NaN%
Moberg Pharma AB (publ)	- SEK	NaN%
Nanexa AB (publ)	29.32 Million SEK	100.0%
Newbury Pharmaceuticals AB (publ)	36.82 Million SEK	100.0%
ODI Pharma AB	22.44 Million SEK	100.0%
Orexo AB (publ)	638.8 Million SEK	100.0%
Probi AB (publ)	627.68 Million SEK	100.0%
Swedencare AB (publ)	2.32 Billion SEK	100.0%
Swedish Orphan Biovitrum AB (publ)	22.12 Billion SEK	100.0%
Toleranzia AB	50.92 Million SEK	100.0%
Vivesto AB	1.01 Million SEK	100.0%